— Know what they know.
Not Investment Advice
Also trades as: XBRA.CN (CNQ) · $vol 0M

XBRAF OTC

Xebra Brands Ltd.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: -99.1% 1Y: -98.5% 3Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 50 · $1525 mcap · 7M float · 0.0002% daily turnover · Short 46% of daily vol

Cash Flow Trends

Operating Cash Flow
-$828K +64.4% ▲
Capital Expenditures
$0 +100.0% ▲
Free Cash Flow
-$828K +65.4% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$100K +77.6% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income-$3M-$2M-$6M-$4M-$2M
Depreciation & Amort.$12K$550K$603K$108K$60K
Stock-Based Comp.$0$0$557K$310K-$2K
Change in Working Capital-$279K$289K-$275K$395K$632K
Other Non-Cash Items$1M$131K$118K$21K$441K
Operating Cash Flow-$2M-$911K-$3M-$2M-$828K
— Investing Activities —
Capital Expenditures-$320K-$145K-$770K-$64K$0
Acquisitions (Net)-$1M$0$0$0$0
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing$0$0$0$0$0
Investing Cash Flow-$2M-$145K-$770K-$64K$0
— Financing Activities —
Net Debt Issuance-$21K-$31K-$196K$0$0
Stock Repurchased-$128K$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$90K$171K$4M$2M$723K
Financing Cash Flow$4M$202K$4M$2M$723K
Net Change in Cash$955K-$862K$554K-$445K-$100K
Cash End of Period$955K$93K$647K$202K$102K
Free Cash Flow-$2M-$1M-$3M-$2M-$828K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms